Howard V. Raff
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Howard V. Raff
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 17 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Howard V. Raff tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member Corporate Officer/Principal | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
| University of California, Los Angeles | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| CODEXIS, INC. | Chemicals: Specialty | Chief Executive Officer Director/Board Member Director of Finance/CFO | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| ESPERION THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Yale University | College/University | Corporate Officer/Principal Graduate Degree | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Stanford University | College/University | Undergraduate Degree Undergraduate Degree | |
| HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY | Pharmaceuticals: Major | Director/Board Member | |
Pequot Capital Corp.
 Pequot Capital Corp. Investment ManagersFinance Pequot Capital Corp. provides investment advisory services. | Investment Managers | Private Equity Investor | |
National Venture Capital Association
 National Venture Capital Association Miscellaneous Commercial ServicesCommercial Services National Venture Capital Association provides business association services. It facilitates networking opportunities and provides research data to its members. The company is headquartered in Washington, DC. | Miscellaneous Commercial Services | Director/Board Member | |
Rivus Pharmaceuticals, Inc.
 Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rivus Pharmaceuticals, Inc. is a company dedicated to improving metabolic health by advancing a new class of medicines called controlled metabolic accelerators (CMAs). The company is based in Charlottesville, VA. Jayson Donald Alexander Dallas has been the CEO of the company since 2021. The company is a leader in mitochondrial biology and is developing a new class of medicines to address a primary driver of cardio-metabolic disease: obesity. Rivus' lead CMA is the investigational small molecule HU6 in development to treat obesity and associated metabolic diseases, including heart failure with preserved ejection fraction (HFpEF), metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH), and type 2 diabetes. | Pharmaceuticals: Major | Director/Board Member | |
| VERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
Dascena, Inc.
 Dascena, Inc. Miscellaneous Commercial ServicesCommercial Services Dascena, Inc. develops machine learning algorithms to enable early disease intervention. The company was founded by Ritankar Das and is headquartered in Oakland, CA. | Miscellaneous Commercial Services | Director/Board Member | |
CuraSen Therapeutics, Inc.
 CuraSen Therapeutics, Inc. BiotechnologyHealth Technology CuraSen Therapeutics, Inc. operates as a biotechnology company. It engages in the discovery and development of therapies to treat neurodegenerative diseases, including parkinson, alzheimer, and less common neurodegenerative disorders. The company was founded by Mehrdad Shamloo, Robert Booth, Anthony Ford, and Kathleen Sereda in 2018 and is headquartered in San Mateo, CA. | Biotechnology | Director/Board Member | |
Epirium Bio, Inc.
 Epirium Bio, Inc. Pharmaceuticals: MajorHealth Technology Epirium Bio, Inc. develops therapeutics for orphan and rare diseases characterized by impairment of the skeletal muscle, cardiac and neuronal systems. The company was founded in 2008 by Alan Stewart Maisel, Sundeep Dugar, and Francisco Villarreal and is headquartered in Los Altos Hills, CA. | Pharmaceuticals: Major | Director/Board Member | |
| APTINYX | Pharmaceuticals: Major | Director/Board Member | |
Lemo USA, Inc.
 Lemo USA, Inc. Electronic ComponentsElectronic Technology Lemo USA, Inc. designs and manufactures custom connectors. It offers low voltage connectors, plastic and miniature connectors, high pressure and high voltage connectors, media converter, and cable assemblies. The company is headquartered in Rohnert Park, CA. | Electronic Components | Director/Board Member | |
| The Trustees of Columbia University in The City of New York | College/University | Doctorate Degree | |
Endeavor BioMedicines, Inc
 Endeavor BioMedicines, Inc Miscellaneous Commercial ServicesCommercial Services Endeavor BioMedicines, Inc is a clinical stage company located in Solana Beach, CA, that develops novel therapies for fibrosis and oncology. The company's lead program, env-101, is a hedgehog signalling inhibitor currently in phase 2 studies treating IPF, a progressive interstitial lung disease that causes inflammation and scarring in the lung. The company's second program is a HER3-targeted ADC that will begin clinical development in 2024 for the treatment of multiple solid tumors. The company's mission is to develop transformative medicines by targeting the underlying genetic and cellular causes of disease with best in class agents. Endeavor is partnered with XCures and is currently looking at the LOF mutation. Regardless of eligibility for the Endeavor trial, XCures will still send a list of other treatment options that could work for the cancer mutation. The company was founded by Miguel A. de los Ríos and John Hood, with John Hood serving as the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Opna Immuno-Oncology SA
 Opna Immuno-Oncology SA BiotechnologyHealth Technology Opna Immuno-Oncology SA is a Swiss biotechnology company that focuses on researching and developing biotechnology products. The private company is based in Saint-Sulpice, Switzerland. | Biotechnology | Director/Board Member | |
Oscient Pharmaceuticals Corp.
 Oscient Pharmaceuticals Corp. Miscellaneous Commercial ServicesCommercial Services Oscient Pharmaceuticals Corp. is a biopharmaceutical company that sells and markets products to community-based primary care physicians through its primary care sales force in the United States. It markets two products namely, ANTARA fenofibrate capsules, a cardiovascular product and FACTIVE gemifloxacin mesylate tablets, a fluoroquinolone antibiotic. It also has late-stage antibiotic candidate, Ramoplanin for the treatment of clostridium difficile-associated disease. The company was founded on May 09, 1961 and is headquartered in Waltham, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| VAXCYTE, INC. | Biotechnology | Director/Board Member | |
| Washington & Jefferson College | College/University | Undergraduate Degree | |
| Icahn School of Medicine at Mount Sinai | College/University | Corporate Officer/Principal | |
| Tufts University | College/University | Corporate Officer/Principal | |
| Walter Reed Army Institute of Research | Corporate Officer/Principal | ||
| Walter Reed Army Medical Center | Corporate Officer/Principal | ||
| Griffintown Capital Partners LLC | Chairman | ||
| OSE Pharmaceuticals | Director/Board Member | ||
Paul Capital Advisors LLC
 Paul Capital Advisors LLC Financial ConglomeratesFinance Part of Paul Capital Partners LP, Paul Capital Advisors LLC provides investment services. The company is based in San Francisco, CA. | Financial Conglomerates | Corporate Officer/Principal | |
Orbus Therapeutics, Inc.
 Orbus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Orbus Therapeutics, Inc. operates as a biopharmaceutical company focused on the development and commercialization of therapies that treat rare diseases. Its product eflornithine is a novel cytostatic agent, which the firm is developing to treat patients with recurrent anaplastic astrocytoma, a rare form of central nervous system cancer. The company was founded by Robert M. Myers and Jason D. Levin in 1998 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director/Board Member | |
Raven Biotechnologies, Inc.
 Raven Biotechnologies, Inc. Miscellaneous Commercial ServicesCommercial Services Raven Biotechnologies, Inc. engages in the development of antibody therapeutics for the treatment for cancer, autoimmune disorders and infectious diseases. Its products are used in treatment of gastrointestinal, lung, colon, pancreatic, prostate, breast, brain, and ovarian cancer. The company was founded in 1999 and is headquartered in South San Francisco, CA. | Miscellaneous Commercial Services | Director/Board Member | |
Sandoz, Inc.
 Sandoz, Inc. Pharmaceuticals: MajorHealth Technology Sandoz, Inc. develops, manufactures and distributes generic pharmaceutical products. The firm focuses on therapeutic drug categories such as anti-infective, central nervous system disorder treatments, cardiovascular medicines, gastrointestinal agent, oncology therapies, and respiratory therapies. The company was founded in 1946 and is headquartered in Princeton, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| THE TRADE DESK, INC. | Packaged Software | Director/Board Member | |
AMO Manufacturing USA LLC
 AMO Manufacturing USA LLC Medical SpecialtiesHealth Technology AMO Manufacturing USA LLC engages in the design, develop and manufacture of excimer refractive surgical systems. It is designed to re-contour the front surface of the cornea of the human eye. The company was founded in 1988 and is headquartered in Santa Clara, CA. | Medical Specialties | Director/Board Member | |
| UROGEN PHARMA LTD. | Biotechnology | Director/Board Member | |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
| ARCUS BIOSCIENCES, INC. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
| Stati Uniti | 43 |
| Irlanda | 4 |
| Svizzera | 3 |
| Francia | 2 |
| Canada | 2 |
Settori
| Health Technology | 24 |
| Consumer Services | 11 |
| Commercial Services | 7 |
| Finance | 3 |
| Process Industries | 2 |
Posizioni
| Director/Board Member | 173 |
| Corporate Officer/Principal | 47 |
| Independent Dir/Board Member | 39 |
| Chief Executive Officer | 23 |
| Director of Finance/CFO | 20 |
Contatti più connessi
| Insiders | |
|---|---|
| James Tananbaum | 60 |
| Patrick Enright | 41 |
| Mark McDade | 35 |
| Kathryn Falberg | 30 |
| Walter Flamenbaum | 26 |
| Mark Iwicki | 26 |
| Stacey Seltzer | 21 |
| Stephen Dilly | 15 |
| Kenneth F. Boehm | 12 |
| Mary M. Rozenman | 8 |
| Bryan L. Walser | 8 |
| Rodney Young | 7 |
| Sriram Ryali | 7 |
| Joon Yun | 5 |
| Mike Holfinger | 5 |
- Borsa valori
- Insiders
- Howard V. Raff
- Connessioni Società
